STAT

SEPTEMBER 23, 2024

1, and the negotiated prices of those drugs take effect in 2027.  Now, all eyes are on which Part D drugs will be chosen for the next round of 15 drugs. Medicare will announce that list by Feb.

Specialty Pharmacies 311

Specialty Pharmacies Diabetes Drug Pricing 311

PharmaVoice

JULY 1, 2024

government, the latest spending projections reveal soon-to-be-implemented price caps will have an impact by 2027. As the first 10 drugs undergo price negotiations with the U.S.

130

130

Putting Patients First Blog

JULY 2, 2024

Clarification on QALY Metrics The NHC appreciates CMS’ commitment to excluding Quality-Adjusted Life Years (QALYs) from the negotiation process as outlined in the 2027 draft guidance. Valuing life differently based on disability status, age, or other special populations is inappropriate.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing HIPAA Labelling 52

STAT

SEPTEMBER 12, 2024

billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate. Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1

Drug Development 296

Drug Development Vaccines 296

STAT

OCTOBER 26, 2023

About 800,000 nurses plan to leave the workforce by 2027, and more than half of newly graduated nurses are leaving the profession within two years. The Kaiser strike is over, for now, but there is no clear resolution in place, and other strikes are still under way or on the horizon.

320

320

PharmaTech

SEPTEMBER 12, 2024

Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.

52

52

STAT

JULY 24, 2023

The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.

Packaging 244

Packaging Drug Pricing Hospitals 244

Putting Patients First Blog

SEPTEMBER 3, 2024

We strongly urge CMS to address these issues in the IPAY 2027 portal to ensure that all participants, regardless of their familiarity with technology or survey formats, can contribute their insights without unnecessary difficulty. Conclusion The NHC appreciates the opportunity to provide input on the IRA 2027 Drug Price Negotiation ICR.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Express Pharma

NOVEMBER 5, 2024

million over a three-year period, ending on June 30, 2027, a filing showed. Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront payments received by Novavax from the health agency. Novavax has agreed to refund $123.8 The first installment payment is due on Nov.

Vaccines 87

Vaccines 87

STAT

DECEMBER 7, 2023

One expires next year and the other in 2027, well beyond the original patent expiration date. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.

Drug Pricing 297

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 297

STAT

OCTOBER 3, 2024

1, 2025, the Centers for Medicare and Medicaid Services will select the costliest prescription medications to negotiate on, with prices coming into effect in 2027.

228

228

PharmaTech

OCTOBER 4, 2024

When the expansion is completed, Piramal expects manufacturing capacity to be increased by the first quarter of 2027 from 104 product batches per year to more than 240.

52

52

STAT

JANUARY 17, 2023

The number of health care-related artificial intelligence models on the market has increased steadily over the past decade, with the health care AI market expected to grow from $7 billion today to $67 billion in 2027.

242

242

BioPharma Dive

NOVEMBER 15, 2023

The deal gives Gilead an estimated 13% ownership in Arcellx and extends the company’s cash runway into 2027.

114

114

Pharmaceutical Commerce

AUGUST 19, 2024

The 86,000 square-foot Køge facility will be fully functional by 2027.

105

105

Outsourcing Pharma

OCTOBER 24, 2023

Traditionally, the pharmaceutical landscape has been dominated by small molecules.

64

64

Pharmaceutical Commerce

APRIL 5, 2023

Rise in value attributed to the ongoing decentralization of pharmacies.

52

52

PharmaTech

OCTOBER 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

52

52

Putting Patients First Blog

SEPTEMBER 20, 2024

Earlier this year CMS released draft guidance for Initial Payment Applicability Year (IPAY) 2027. This guidance will apply to the negotiation process for 15 drugs, which will occur next year, and the resulting prices will take effect in 2027. Conclusion To read the NHC’s full comments, click here and here.

Drug Pricing 52

Drug Pricing Communication Vaccines 52

Pharmaceutical Commerce

AUGUST 30, 2024

The 3PL plans to convert all its trucks to electric by 2027.

52

52

Pharmaceutical Technology

MAY 23, 2024

The cost saving programme is expected run over multiple years and will save the company about $1.5bn by 2027.

52

52

STAT

JUNE 25, 2024

The company said that it expects to add 1,000 new jobs, and that construction will gradually be finalized between 2027 and 2029. Novo Nordisk said the new facility would expand over 56 acres and add 1.4 million square feet of production space, doubling the combined square footage of the other three facilities in North Carolina.

234

234

PharmExec

FEBRUARY 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

40

40

Pharmaceutical Technology

OCTOBER 6, 2023

Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.

59

59

Pharmacy Times

JANUARY 10, 2023

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

52

52

STAT

NOVEMBER 20, 2023

Under the new agreement, the level of allowed growth in drug sales will increase from 2% in 2024 to 4% by 2027. The current plan, which has drawn the ire of pharma companies, requires drug companies to pay rebates back to the U.K. if spending on medicines increases by more than 2% a year. Continue to STAT+ to read the full story…

239

239

pharmaphorum

SEPTEMBER 12, 2024

billion a year from 2027, reversing years of growth made possible by sales of its COVID-19 vaccines. Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1

Vaccines 45

Vaccines 45

STAT

SEPTEMBER 12, 2024

billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. So here are some items of interest. Have a great day, everyone. … Moderna plans to cut its annual spending on research and development by 23%, or $1.1

Packaging 139

Packaging Diabetes Vaccines 139

Express Pharma

DECEMBER 13, 2023

Commercialisation is targeted for 2027 Asahi Kasei has developed a novel membrane system for dehydrating organic solvents for pharma applications without the application of heat or pressure. This system can contribute to the optimisation of manufacturing processes in the pharma industry.

Pharmaceutical Manufacturing 94

Pharmaceutical Manufacturing 94

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

The commission’s investigation was made public last week by the health department and the Health Justice Initiative (HJI) legal organisation at a media briefing of Médecins Sans Frontières (MSF).

Drug Pricing 98

Drug Pricing 98

Express Pharma

AUGUST 5, 2024

The Department of Pharmaceuticals is implementing the Production Linked Incentive (PLI) Scheme for Pharmaceuticals with a total financial outlay of Rs 15,000 crore and scheme tenure up to FY 2027-28. The product Category 1 covers drugs such as bio-pharmaceuticals, complex generics, gene therapy drugs, complex excipients, orphan drugs etc.

93

93

Pharmaceutical Commerce

JANUARY 25, 2023

Annual report finds continuing impact of COVID-19 on global markets

52

52

European Pharmaceutical Review

NOVEMBER 18, 2024

These will be available for marketing from 2027, according to Sanofi. Supporting production of diabetes medicine Development of the Lyon Gerland site enables internal production of a drug for patients with preclinical type 1 diabetes, previously produced outside the EU and not by Sanofi.

Diabetes 64

Diabetes 64

European Pharmaceutical Review

AUGUST 27, 2024

Manufacturing of the biologic products in the expanded Sweden Biomanufacturing Center is planned to begin from Q4 of 2027, according to AstraZeneca. “We are happy about this investment in Södertälje, which demonstrates AstraZeneca’s commitment to innovation and manufacturing of biological medicines in Sweden”, Alfredsson continued.

115

115

Pharmafile

JANUARY 25, 2023

The facility is expected to become operational in 2027 and will create over 100 new jobs for manufacturing personnel. Lilly’s expansion is set to include the addition of further parenteral filling, device assembly and packaging capacity in order to meet the growing demand for the company’s incretin-based diabetes treatments and medications.

Packaging 52

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 15, 2023

The committee has also launched new targets for December 2027. Additionally, 50 of the private companies in the UK need to have a minimum of one ethnic minority director on the main board by December 2027. Under these targets, each FTSE 350 company will be required to set a percentage target for senior management positions.

52

52

pharmaphorum

JANUARY 4, 2022

An appeals court ruling has upheld the validity of a key US patent covering Gilenya (fingolimod), and issued a permanent injunction against HEC Pharma until it expires in December 2027. Generics could still appear on the US market before the end of 2027 however.

59

59